Cargando…

DrugHybrid_BS: Using Hybrid Feature Combined With Bagging-SVM to Predict Potentially Druggable Proteins

Drug targets are biological macromolecules or biomolecule structures capable of specifically binding a therapeutic effect with a particular drug or regulating physiological functions. Due to the important value and role of drug targets in recent years, the prediction of potential drug targets has be...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Yuxin, Liao, Bo, Wang, Peng, Zou, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669608/
https://www.ncbi.nlm.nih.gov/pubmed/34916947
http://dx.doi.org/10.3389/fphar.2021.771808
_version_ 1784614813125574656
author Gong, Yuxin
Liao, Bo
Wang, Peng
Zou, Quan
author_facet Gong, Yuxin
Liao, Bo
Wang, Peng
Zou, Quan
author_sort Gong, Yuxin
collection PubMed
description Drug targets are biological macromolecules or biomolecule structures capable of specifically binding a therapeutic effect with a particular drug or regulating physiological functions. Due to the important value and role of drug targets in recent years, the prediction of potential drug targets has become a research hotspot. The key to the research and development of modern new drugs is first to identify potential drug targets. In this paper, a new predictor, DrugHybrid_BS, is developed based on hybrid features and Bagging-SVM to identify potentially druggable proteins. This method combines the three features of monoDiKGap (k = 2), cross-covariance, and grouped amino acid composition. It removes redundant features and analyses key features through MRMD and MRMD2.0. The cross-validation results show that 96.9944% of the potentially druggable proteins can be accurately identified, and the accuracy of the independent test set has reached 96.5665%. This all means that DrugHybrid_BS has the potential to become a useful predictive tool for druggable proteins. In addition, the hybrid key features can identify 80.0343% of the potentially druggable proteins combined with Bagging-SVM, which indicates the significance of this part of the features for research.
format Online
Article
Text
id pubmed-8669608
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86696082021-12-15 DrugHybrid_BS: Using Hybrid Feature Combined With Bagging-SVM to Predict Potentially Druggable Proteins Gong, Yuxin Liao, Bo Wang, Peng Zou, Quan Front Pharmacol Pharmacology Drug targets are biological macromolecules or biomolecule structures capable of specifically binding a therapeutic effect with a particular drug or regulating physiological functions. Due to the important value and role of drug targets in recent years, the prediction of potential drug targets has become a research hotspot. The key to the research and development of modern new drugs is first to identify potential drug targets. In this paper, a new predictor, DrugHybrid_BS, is developed based on hybrid features and Bagging-SVM to identify potentially druggable proteins. This method combines the three features of monoDiKGap (k = 2), cross-covariance, and grouped amino acid composition. It removes redundant features and analyses key features through MRMD and MRMD2.0. The cross-validation results show that 96.9944% of the potentially druggable proteins can be accurately identified, and the accuracy of the independent test set has reached 96.5665%. This all means that DrugHybrid_BS has the potential to become a useful predictive tool for druggable proteins. In addition, the hybrid key features can identify 80.0343% of the potentially druggable proteins combined with Bagging-SVM, which indicates the significance of this part of the features for research. Frontiers Media S.A. 2021-11-30 /pmc/articles/PMC8669608/ /pubmed/34916947 http://dx.doi.org/10.3389/fphar.2021.771808 Text en Copyright © 2021 Gong, Liao, Wang and Zou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Gong, Yuxin
Liao, Bo
Wang, Peng
Zou, Quan
DrugHybrid_BS: Using Hybrid Feature Combined With Bagging-SVM to Predict Potentially Druggable Proteins
title DrugHybrid_BS: Using Hybrid Feature Combined With Bagging-SVM to Predict Potentially Druggable Proteins
title_full DrugHybrid_BS: Using Hybrid Feature Combined With Bagging-SVM to Predict Potentially Druggable Proteins
title_fullStr DrugHybrid_BS: Using Hybrid Feature Combined With Bagging-SVM to Predict Potentially Druggable Proteins
title_full_unstemmed DrugHybrid_BS: Using Hybrid Feature Combined With Bagging-SVM to Predict Potentially Druggable Proteins
title_short DrugHybrid_BS: Using Hybrid Feature Combined With Bagging-SVM to Predict Potentially Druggable Proteins
title_sort drughybrid_bs: using hybrid feature combined with bagging-svm to predict potentially druggable proteins
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669608/
https://www.ncbi.nlm.nih.gov/pubmed/34916947
http://dx.doi.org/10.3389/fphar.2021.771808
work_keys_str_mv AT gongyuxin drughybridbsusinghybridfeaturecombinedwithbaggingsvmtopredictpotentiallydruggableproteins
AT liaobo drughybridbsusinghybridfeaturecombinedwithbaggingsvmtopredictpotentiallydruggableproteins
AT wangpeng drughybridbsusinghybridfeaturecombinedwithbaggingsvmtopredictpotentiallydruggableproteins
AT zouquan drughybridbsusinghybridfeaturecombinedwithbaggingsvmtopredictpotentiallydruggableproteins